eXoZymes Inc
EXOZ
NASDAQ
Biotechnology
$5.82
USD
-0.18 (-3.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $48.26M
Volume 9.1K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-9.67M
TTM
— YoY
Operating Cash Flow
$-6.89M
TTM
— YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.4 | 1.7 | 1.3 | 1.6 | 1.3 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 2.0 | 2.5 | 2.5 | 2.7 | 2.4 |
Operating Income | -2.0 | -2.5 | -2.5 | -2.7 | -2.4 |
EBITDA | -1.9 | -2.5 | -2.5 | -2.6 | -2.3 |
Other Income / Expense | 0.0 | 0.1 | 0.2 | -0.2 | 0.0 |
Total Other Income / Expense | 0.1 | 0.2 | 0.2 | -0.1 | 0.0 |
Income Before Income Taxes | -1.9 | -2.4 | -2.3 | -2.8 | -2.4 |
Income Taxes | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 |
Net Income | -1.9 | -2.4 | -2.3 | -2.7 | -2.4 |
Consolidated Net Income / Loss | -1.9 | -2.4 | -2.3 | -2.7 | -2.4 |
Net Income Attributable to Common Shareholders | -1.9 | -2.4 | -2.3 | -2.7 | -2.4 |
Basic EPS | -$0.22 | -$0.28 | -$0.27 | -$0.32 | -$0.28 |
Diluted EPS | -$0.22 | -$0.28 | -$0.27 | -$0.32 | -$0.28 |
Basic Shares Outstanding | 8.4M | 8.4M | 8.4M | 8.4M | 8.5M |
Diluted Shares Outstanding | 8.4M | 8.4M | 8.4M | 8.4M | 8.5M |